Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 206,952 | +206,952 | $0 | $21.96M | 8.90% | +$21.96M |
| Disc Medicine, Inc.(IRON) | 518,177 | 396,115 | -122,062 | $25.72M | $20.98M | 8.50% | -$4.74M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 2,426,436 | 3,260,570 | +834,134 | $8.59M | $20.90M | 8.47% | +$12.31M |
| Vaxcyte, Inc.(PCVX) | 232,295 | 544,221 | +311,926 | $8.77M | $17.69M | 7.17% | +$8.92M |
| Cogent Biosciences, Inc.(COGT) | 1,480,020 | 2,297,524 | +817,504 | $8.87M | $16.50M | 6.69% | +$7.63M |
| Celcuity Inc.(CELC) | 1,093,677 | 1,185,520 | +91,843 | $11.06M | $15.83M | 6.41% | +$4.77M |
| CG Oncology, Inc.(CGON) | 577,696 | 586,647 | +8,951 | $14.15M | $15.25M | 6.18% | +$1.11M |
| Xenon Pharmaceuticals Inc.(XENE) | 413,711 | 468,364 | +54,653 | $13.88M | $14.66M | 5.94% | +$779.8K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 1,455,429 | +1,455,429 | $0 | $13.86M | 5.62% | +$13.86M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 343,849 | 290,784 | -53,065 | $13.43M | $13.73M | 5.56% | +$290.8K |
| Merus N V | 323,211 | 224,260 | -98,951 | $13.60M | $11.80M | 4.78% | -$1.81M |
| Centessa Pharmaceuticals PlcADS | 448,692 | 793,327 | +344,635 | $6.45M | $10.42M | 4.22% | +$3.97M |
| LENZ Therapeutics, Inc.(LENZ) | 0 | 342,312 | +342,312 | $0 | $10.03M | 4.07% | +$10.03M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 58,181 | +58,181 | $0 | $7.31M | 2.96% | +$7.31M |
| Ocular Therapeutix, Inc.(OCUL) | 598,191 | 728,576 | +130,385 | $4.38M | $6.76M | 2.74% | +$2.38M |
| Ascendis Pharma A/SADR(ASND) | 199,264 | 38,191 | -161,073 | $31.06M | $6.59M | 2.67% | -$24.47M |
| argenx SEADR(ARGX) | 13,862 | 10,285 | -3,577 | $8.20M | $5.67M | 2.30% | -$2.54M |
| ABIVAX Société AnonymeADS(ABVX) | 552,926 | 622,479 | +69,553 | $3.46M | $4.76M | 1.93% | +$1.31M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,041,280 | 500,551 | -540,729 | $12.79M | $4.69M | 1.90% | -$8.10M |
| Newamsterdam Pharma Company ORDINARY SHARES | 116,353 | 220,695 | +104,342 | $2.38M | $4.00M | 1.62% | +$1.62M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 560,979 | 319,348 | -241,631 | $3.92M | $1.27M | 0.51% | -$2.65M |
| Replimune Group, Inc.(REPL) | 0 | 128,917 | +128,917 | $0 | $1.20M | 0.49% | +$1.20M |
| Kalvista Pharmaceuticals Inc | 255,060 | 62,793 | -192,267 | $2.94M | $709.9K | 0.29% | -$2.23M |
| Silence Therapeutics plcADS(SLN) | 732,463 | 34,737 | -697,726 | $2.07M | $201.5K | 0.08% | -$1.86M |
| Crinetics Pharmaceuticals In | 59,017 | 0 | -59,017 | $1.98M | $0 | — | -$1.98M |
| Inozyme Pharma Inc | 499,254 | 0 | -499,254 | $454.3K | $0 | — | -$454.3K |